Press

Newsroom

Quantitative ex vivo synergy profiling uncovers heterogeneous combination responses in AML primary samples

67th ASH Annual Meeting and Exposition
Learn More →

Ex vivo drug sensitivity testing in Korean AML patients: Integration of functional and genomic profiles for predicting clinical response and survival

67th ASH Annual Meeting and Exposition
Learn More →

A multi-institutional machine-learning score that predicts bacteremia and gram class at blood-culture initiation

67th ASH Annual Meeting and Exposition
Learn More →

Large-Scale Validation of a Flow Cytometry Platform for Comprehensive Immunophenotyping, Cell Size Determination, and Prognostic Stratification in Canine Lymphomas

Veterinary Cancer Society Annual Conference 2025
Learn More →

Lumps, Lab Work, and a Little AI: A Tech’s Guide to Canine Lymphoma

Veterinary Cancer Society Annual Conference 2025
Learn More →

When AI Disappoints: Improving Outcomes with Real-World Clinical Data

Veterinary Cancer Society Annual Conference 2025
Learn More →

Ethos Discovery Stratified Outcomes for Lymphoma in Dogs (SOLID) Study: Informing Subclassification & Prognosis

ACVIM Forum 2025
Learn More →

Chemotherapy selection for advanced or metastatic pancreatic cancer using machine learning models trained with multi-center datasets

2025 ASCO Gastrointestinal Cancers Symposium
Learn More →

Optimizing the first line therapy of canine B-cell lymphomas via machine learning

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY) 2.0
Learn More →

A study on the relationship between ex vivo drug sensitivity and clinical outcome of acute lymphoblastic leukemia

AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
Learn More →

Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics

Veterinary Cancer Society Annual Conference 2024
Learn More →

Decoding Feline Lymphoma: From Diagnosis to Prognosis

Veterinary Cancer Society Annual Conference 2024
Learn More →

Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning

Veterinary Cancer Society Annual Conference 2024
Learn More →

Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning

ASCO Breakthrough 2024
Learn More →

Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024
Learn More →

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024
Learn More →

AI-driven Personalized Medicine for Cancer Care

Precision Medicine World Conference 2024
Learn More →